{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"17.09","value":"83.2"},{"groupId":"OG001","spread":"15.73","value":"83.0"}]}],"title":"POMS Tension-Anxiety Subscale"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"18.42","value":"31.1"},{"groupId":"OG001","spread":"19.61","value":"33.0"}]}],"title":"POMS VA Subscale"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"14.48","value":"87.8"},{"groupId":"OG001","spread":"12.98","value":"87.7"}]}],"title":"POMS Anger-Hostility Score"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"17.58","value":"76.9"},{"groupId":"OG001","spread":"11.75","value":"77.9"}]}],"title":"POMS Confusion-Bewilderment"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"16.09","value":"86.4"},{"groupId":"OG001","spread":"15.23","value":"85.8"}]}],"title":"POMS Depression-Dejection Score"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"21.69","value":"67.2"},{"groupId":"OG001","spread":"22.22","value":"63.6"}]}],"title":"POMS Fatigue-Inertia Score"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"13.27","value":"71.5"},{"groupId":"OG001","spread":"13.14","value":"71.8"}]}],"title":"Mean POMS Score"}],"denoms":[{"counts":[{"groupId":"OG000","value":"101"},{"groupId":"OG001","value":"102"}],"units":"Participants"}],"description":"Each mood scale (0 - 100, higher is better mood) will be analyzed as an endpoint along with the total mood disturbance score.","dispersionType":"Standard Deviation","groups":[{"description":"Patients apply 1 spoonful of baclofen-amitriptyline hydrochloride-ketamine gel topically to each area of pain, numbness, and/or tingling on the feet and/or hands twice daily for 4 weeks. Baclofen/amitriptyline/ketamine gel: Applied topically.","id":"OG000","title":"Baclofen-amitriptyline Hydrochloride-ketamine"},{"description":"Patients apply 1 spoonful of placebo gel topically to each area of pain, numbness, and/or tingling on the feet and/or hands twice daily for 4 weeks. Placebo: Applied topically","id":"OG001","title":"Placebo"}],"paramType":"MEAN","reportingStatus":"POSTED","timeFrame":"At 4 weeks","title":"Mood States and Total Mood Disturbance as Measured by the Profile of Mood States (POMS)","type":"SECONDARY","unitOfMeasure":"units on a scale"}